Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Mr. James Blome

Market Cap

20.03 Million USD

Sector

Consumer Defensive

Website

https://calyxt.com

Description

Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States.

Read More

Overview

Value

1

Growth

55

Health

37

Management

51

Analyst Opinion

69

Total

43

All Scores Out Of 100

Best Features

  • Earnings growth has improved recently
  • Has a low level of debt
  • Low preportion of income is paid as dividend
  • 0

Risk Factors

  • Overvalued on cashflow basis
  • Income is not covering expenditure and investment
  • Earnings are negative
  • There is a history of diluting shareholders
  • 0
  • No margin of safety at their current market price

Market Peers

CLXT

Key Figures

PE Ratio (TTM)

N/A

Margin Of Safety (DCF)

-1367.43%

Revenue Growth (5 Year Average)

30.68%

Ratings Consensus

Buy

Share Buybacks

-3.36%

Dividend Yeild (TTM)

N/A

Valuation

Value Score

1

  • Estimated intrinsic-value of NaN undefined USD is lower than current price ( 410.00 undefined USD)
  • Free-cashflow-yeild of -117.18% is worse than the market average (4.7%)
  • Margin-of-safety of -1367.43% is worse than the market average (17.95%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: N/A

Current Price: 0.4 USD

Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

N/Ax

Free Cashflow Yeild

-117.18%

PE/Earnings Growth

N/A

Price/Book

2.02x

Growth

Growth Score

55

  • 5 Year Average Revenue growth of 30.68% is higher than the market average (10.97%)
  • Earnings growth has improved this year
  • Free Cashflow growth has improved this year
  • Revenue growth has slowed this year
  • 5 Year Average Earnings growth of 5.52% is lower than the market average (14.48%)
  • 5 Year Average Free Cashflow growth of 2.84% is lower than the market average (12.35%)

Revenue Growth

30.68%

Earnings Growth

5.52%

Cashflow Growth

2.84%

Health

Health Score

37

  • Has a low level of debt
  • Assets cover liabilities
  • Low financial Leverage
  • Normal operation does not require debt to be sustainable
  • Cashflow is negative
  • 0
  • Debt repayments significantly impact cashflow

Altman Z Score

N/A

Piostroski Score

3.00

Debt/Equity

0.03x

Current Assets/Liabilities

3.13x

Free Cashflow/Total Debt

N/Ax

Debt/Capital

0.02x

Management

Management Score

51

  • Has issued new shares to finance growth when share price is high
  • Return-on-capital-employed of -58.32% is lower than the market average (10%)
  • Has a history of diluting shareholders to finance activity
  • Return-on-equity of -270.71% is lower than the market average (15%)

Average Buybacks/Dilution

-3.36%

Recent Buybacks/Dilution

44.16%

5 Year Price Volitility

63.39%

Return On Assets

-102.86%

Return On Capital Employed

-58.32%

Return On Equity

-270.71%

Return On Free Cashflow

84.16%

Return On Investments

N/A

Analysts

Analyst Opinion

69

  • Ratings consensus is Buy

SEC Filings

Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

Other Information

Company Name

Calyxt, Inc.

Currency

USD

Beta

1.756539

Vol Avg

1937960

Ceo

Mr. James Blome

Cik

0001705843

Cusip

13173L107

Exchange

NASDAQ Global Market

Full Time Employees

55

Industry

Packaged Foods

Sector

Consumer Defensive

Ipo Date

2017-07-20

Address

2800 Mount Ridge Rd

City

Roseville

State

MINNESOTA

Country

US

Zip

55113-1127

Phone

16516832807

All financial data provided by FMP

Noticed an error with something on our site?

We Use Cookies